Systematic (IUPAC) name | |
---|---|
5-hydroxy-1-β-D-ribofuranosyl-1H-imidazole-4-carboxamide | |
Clinical data | |
AHFS/Drugs.com | International Drug Names |
Pregnancy cat. | ? |
Legal status | ℞ Prescription only |
Routes | Oral |
Identifiers | |
CAS number | 50924-49-7 |
ATC code | None |
PubChem | CID 104762 |
UNII | 4JR41A10VP |
KEGG | D01392 |
Synonyms | 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-hydroxyimidazole-4-carboxamide |
Chemical data | |
Formula | C9H13N3O6 |
Mol. mass | 259.21 g/mol |
SMILES | eMolecules & PubChem |
(verify) |
(what is this?)
Mizoribine (INN, trade name Bredinin) is an immunosuppresive drug. The compound was first observed in Tokyo, Japan, in 1971.[1] It is a natural product, first isolated from the mould Eupenicillium brefeldianum.